4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-25-094576
Chief Executive Officer sold 735 shares at $3.38 ($2,484)
- Chief Executive Officer acquired 1,360 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2025-07-03 | Option exercise | +1,360 | 4,757 | D | ||
| Schambye Hans T. Chief Executive Officer | 2025-07-03 | Sale | −735 | $3.38 | $2,484 | 4,022 | D |
| Derivatives | |||||||
| Schambye Hans T. Chief Executive Officer | 2025-07-03 | Option exercise · Restricted Stock Units | −1,360 | 4,000 | D | ||
| Open-market sales · 735 sh · avg $3.38 · $2,484 | |||||||
Loading xslF345X05/ownership.xml…